Explore chapters and articles related to this topic
Cancer Incidence and Mortality: In India and Worldwide
Published in Anjana Pandey, Saumya Srivastava, Recent Advances in Cancer Diagnostics and Therapy, 2022
Anjana Pandey, Saumya Srivastava
Age is the most vital factor for ovarian cancer, alongside the family history of this disease (Ridgeway et al., 2017; Forman et al., 2018; Sundar et al., 2018; Wittenberg et al., 2018; Bennetsen et al., 2020; Cabasag et al., 2020; Zheng et al., 2020; Hemmingsen et al., 2021). Women having inherited mutations of BRCA1 or BRCA2 genes or genes related to Lynch syndrome are found to be at higher risk (Shulman, 2010; Minion et al., 2015; Hall et al., 2016; Evans et al., 2018; Gockley et al., 2018; Samtani and Saksena, 2019; Rush et al., 2020; Cowan et al., 2021; Hickey et al., 2021; Wong et al., 2021). Other medical characteristics responsible for ovarian cancer are endometriosis, inflammatory disease of the pelvis region, and personal and family breast or ovarian cancer. Additionally, other factors responsible for ovarian cancer are menopausal hormonal therapy or hormonal replacement therapy. In the mucinous subtype, cigarette smoking is responsible. Use of oral contraceptives, pregnancy, and fallopian tube removal are the factors responsible in the case of lower risk (Pujade-Lauraine et al., 2017; Friedlander et al., 2018).
The World Trade Center Health Program: Cancer screening and cancer care best practices
Published in Archives of Environmental & Occupational Health, 2023
Geoffrey M. Calvert, Gerald Lilly, John Cochran
The 2021 USPSTF update recommends that individuals at average risk and aged 45–75 years of age be screened for colorectal cancer (persons at average risk are those with no prior diagnosis of colorectal cancer, adenomatous polyps, or inflammatory bowel disease, and no personal diagnosis or family history of known genetic disorders that predispose them to a high lifetime risk of colorectal cancer [such as Lynch syndrome or familial adenomatous polyposis]). There are several recommended screening strategies including colonoscopy, flexible sigmoidoscopy, high-sensitivity guaiac fecal occult blood testing, and fecal immunochemical testing (Table 1).14 Details can be found at this link: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening. Using data from 2015, it was estimated that 63% of US adult women and 62% of US adult men aged 50 to 75 years were up to date for colorectal cancer screening.15